NAVERIS

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch Mar 24, 2020 | Molika Ashford NEW YORK – Investigators from the University of North Carolina at Chapel Hill have reached a new milestone for their virus-associated oropharyngeal cancer detection assay, publishing validation data for the test, while a startup has begun to provide the test to early adopters. Appearing last month in the Journal of Clinical Oncology, the group’s study confirmed that the liquid…

0
Read More

HEALIO–Liquid biopsy test confirms remission in HPV-associated oral cancer

Liquid biopsy test confirms remission in HPV-associated oral cancer October 24, 2018 A novel liquid biopsy test showed compelling specificity and sensitivity in detecting HPV DNA among patients who underwent chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma, according to findings presented at the American Society for Radiation Oncology Annual Meeting. “This blood test has exceptional performance in monitoring patients for cancer recurrence after radiation therapy,” Bhisham Chera, MD, an associate professor of radiation oncology at The University of North Carolina…

0
Read More

DENTISTRY TODAY–Blood Test Confirms Remission in HPV-Associated Oral Cancer Patients

Blood Test Confirms Remission in HPV-Associated Oral Cancer Patients 25 Oct 2018 Dentistry Today   UNC Lineberger’s Bhishamjit S. Chera, MD, and Gaorav Gupta, MD, PhD. A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC) are free from cancer following radiation therapy, according to researchers at the University of North Carolina (UNC) at Chapel Hill. The liquid biopsy test, which measures fragments…

0
Read More

GENOMEWEB–Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer

Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer Oct 25, 2018 | Molika Ashford NEW YORK (GenomeWeb) – Investigators shared data this week from a small prospective trial of a blood-based method they developed to test patients with human papillomavirus-associated oral cancers for signs of remission or recurrence. The approach, which was spearheaded by researchers at the University of North Carolina and is being commercialized by startup Naveris, would potentially allow doctors to more accurately…

0
Read More

MEDSCAPE–Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer

Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer Roxanne Nelson, BSN, RN October 24, 2018 The so-called liquid biopsy holds great promise for detecting a variety of cancers more accurately, guiding individualized therapy, and improving monitoring during treatment. New data suggest that testing for plasma circulating tumor human papillomavirus DNA (ctHPVDNA) can be an effective method of surveillance for patients with p16-positive oropharyngeal squamous cell carcinoma (OPSCC). The performance of an optimized multianalyte ctHPVDNA blood test for detecting cancer recurrence was “exceptional,”…

0
Read More